Utilising Almac’s UK & US commercial facilities, a global speciality healthcare company benefited from Almac’s expertise in integrated commercial product transfer for two of its branded generic products in the US market, completing technology transfer, CBE-30 approvals and finished pack commercial supply within a 10 month timeframe.